About Apogee Therapeutics
Apogee Therapeutics Inc is a biotechnology firm based in Waltham, Massachusetts, focusing on creating innovative treatments for atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other related conditions. The company is known for its development of groundbreaking monoclonal antibodies, including APG777 for AD and APG808 for COPD, aiming to improve patients' lives through advanced biologics. Founded in 2022, Apogee Therapeutics is at the forefront of addressing unmet medical needs in inflammatory and immunology indications.
APGE Coverage
8:15am ET
Investing
Pre-Market Stock Futures: Futures are trading higher this morning, but if you’ve ever heard the old saying, “when the chips are down”, that was the poster child phrase for Tuesday’s session,…
